Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy

Publisher： Karger

E-ISSN： 1423-0232|89|3|159-166

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.3, 2015-05, pp. : 159-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Residual Cancer Stem Cells after Interval Cytoreductive Surgery following Neoadjuvant Chemotherapy Could Result in Poor Treatment Outcomes for Ovarian Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 324-330

Karger

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 331-340

Karger

Access to resources Recommend Favorite

Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 6, 2015-05 ,pp. : 843-849

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature

By  

Oncology, Vol. 91, Iss. 4, 2016-08 ,pp. : 211-216

Karger

Access to resources Recommend Favorite